Magnetic resonance imaging contrast enhancement via paramagnetic effect

Magnetic resonance imaging contrast enhancement via paramagnetic effect refers to the process by which contrast agents containing paramagnetic metal ions (mostly gadolinium, manganese, or iron oxide) improve the visibility of tissues in MRI scans. These agents work by altering the relaxation times (T1 and T2) of nearby water protons by their strong localized magnetic fields, thus creating greater differentiation between normal and abnormal tissues. The most widely used agents are gadolinium chelates, which are primarily "positive" agents (they increase signal intensity in T1-weighted images). Manganese-based and iron oxide-based agents are used less frequently, with manganese agents providing enhanced T1 effects and superparamagnetic iron oxides providing T2 effects. These agents are used across a broad range of diagnostic applications, but their use is tempered by concerns regarding nephrotoxicity, tissue deposition, and rare allergic reactions[1][2][3][4][5][6][7][8].

Other names

MRI contrast enhancement via paramagnetic effectParamagnetic MRI contrast agent actionParamagnetic relaxation enhancement

Paramagnetic ion alters local magnetic field, shortening T1 and/or T2 relaxation times of nearby water protons, resulting in increased or decreased signal intensity on MRI images[1][2][3][4][5][6][8].